-
Reliability Test of the Hungarian Versions of the Hypertension Knowledge Test and the QLICD-HY Quality of Life Assessment Questionnaire Among People With High Blood Pressure
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Image-Guided Ablation vs. Conventional Ablation in Patients With Recurrent Ventricular Tachycardia: Results From the inEurHeart Trial
Sep 9, 2025, 16:22 PM -
Investigation of Patient Satisfaction With Home Nursing Care Among Recipients
Sep 9, 2025, 16:22 PM -
Analysis of the Fiscal and Socioeconomic Impact of a National Social Program to Support In Vitro Fertilization in Romania: A Generational Accounting Model
Sep 9, 2025, 16:22 PM -
Quality of Life of Patients Living With Epilepsy in Hungary
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Modifying Cardiovascular Disease Risk Factors in Qatar Using the Productivity-Adjusted Life Years (PALY) Metric
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Mortality After Diabetic Ketoacidosis: Insights From Linked Primary- and Secondary-Care Data in the UK
Sep 9, 2025, 16:22 PM -
Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Information in Early Stage Health Technology Assessment: Guiding Investment in Evidence Generation
Sep 9, 2025, 16:22 PM -
Does Proposed IRP Introduction in the US Align With Current IRP Trends and With Best Practice Guidelines?
Sep 9, 2025, 16:22 PM -
Association Between ALK Tyrosine Kinase Inhibitor and the Risk of Interstitial Lung Disease and Pneumonitis in Non-Small Cell Lung Cancer Patients: A Systematic Review
Sep 9, 2025, 16:22 PM -
Simulating PICOs to Predict Evidence Requirement Implications of the EU Joint Clinical Assessment: Learnings From 24 Case Studies
Sep 9, 2025, 16:22 PM -
Real-World Cancer Treatments for Common Solid Tumors in China: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Assessing the Value of Purewick™ System for the Management of Female Patients With Urinary Incontinence in the Nonacute Setting: Preliminary Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation
Sep 9, 2025, 16:22 PM -
Data Linkage in Practice: A Living Systematic Review of Clinical Trials in the United States (US) Utilizing Linkage to Real-World Data
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in France, Italy, Spain, and Germany
Sep 9, 2025, 16:22 PM -
Modeled Number and Cost of Biparametric Magnetic Resonance Imaging (bpMRI) Examinations in a Nationwide Prostate Cancer Screening Program: Utilizing the Results of the Czech Prostapilot Study
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM
